Universe Pharmaceuticals Inc (UPC) — Capital Reinvestment Ratio
Latest as of March 2025:
0.04x
Universe Pharmaceuticals Inc (UPC) has a Capital Reinvestment Ratio of 0.04x as of March 2025, meaning it reinvests 0% of its operating cash flow ($2.56 Million) in capital expenditures ($96.78K). See UPC cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.04x
Capex / Operating Cash Flow
Operating Cash Flow
$2.56 Million
USD
Capital Expenditures
$96.78K
USD
Data as of
Mar 2025
Most recent filing
Universe Pharmaceuticals Inc Capital Reinvestment Ratio (2018–2023)
This chart tracks Universe Pharmaceuticals Inc's Capital Reinvestment Ratio across 4 annual periods.
Annual Capital Reinvestment Ratio for Universe Pharmaceuticals Inc (2018–2023)
Year-by-year Capital Reinvestment Ratio for Universe Pharmaceuticals Inc from 2018 to 2023. For live market cap and broader valuation context, see Universe Pharmaceuticals Inc market capitalisation.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2023 | 0.04x | $1.12 Million | $44.17K | ▲ +365.6% |
| 2020 | 0.01x | $6.12 Million | $51.80K | ▲ +29.6% |
| 2019 | 0.01x | $13.20 Million | $86.32K | ▼ -79.9% |
| 2018 | 0.03x | $4.46 Million | $145.09K | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow